Morningstar

BlackRock Health Sciences Opportunities Portfolio Investor C Shares SHSCX

Morningstar Medalist Rating
Medalist Rating as of | See BlackRock Investment Hub
  • NAV / 1-Day Return 47.10  /  −1.67 %
  • Total Assets 6.2B
  • Adj. Expense Ratio
    1.900%
  • Expense Ratio 1.890%
  • Distribution Fee Level Below Average
  • Share Class Type Level Load
  • Category Health
  • Investment Style Large Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.00
  • Turnover 49%

USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:55 AM GMT+0

Morningstar’s Analysis SHSCX

Will SHSCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable SHSCX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the SHSCX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of SHSCX’s parent organization’s priorities and whether they’re in line with investors’ interests.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

BlackRock Health Sciences Opps Inv C holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

by Morningstar Automated Analysis
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SHSCX

More SHSCX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 53.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

11.92 760M
Healthcare

Johnson & Johnson

8.03 512M
Healthcare

Merck & Co Inc

5.56 355M
Healthcare

AbbVie Inc

5.07 323M
Healthcare

Thermo Fisher Scientific Inc

4.41 281M
Healthcare

UnitedHealth Group Inc

4.33 276M
Healthcare

Gilead Sciences Inc

4.09 261M
Healthcare

Amgen Inc

3.98 254M
Healthcare

Vertex Pharmaceuticals Inc

3.33 212M
Healthcare

Abbott Laboratories

2.61 167M
Healthcare

Sponsor Center